These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8505874)

  • 21. Reduction of spontaneous alcohol drinking and physical withdrawal by levemopamil, a novel Ca2+ channel antagonist, in rats.
    Rezvani AH; Pucilowski O; Grady DR; Janowsky D; O'Brien RA
    Pharmacol Biochem Behav; 1993 Oct; 46(2):365-71. PubMed ID: 8265691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective role of ornithine decarboxylase activation in transient focal cerebral ischaemia: a study using ornithine decarboxylase-overexpressing transgenic rats.
    Lukkarinen JA; Kauppinen RA; Gröhn OH; Oja JM; Sinervirta R; Järvinen A; Alhonen LI; Jänne J
    Eur J Neurosci; 1998 Jun; 10(6):2046-55. PubMed ID: 9753092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pre-ischaemic neuroprotective effects of the polyamine analogues BU43b and BU36b in permanent and transient focal cerebral ischaemia models in mice.
    Li J; Henman MC; Atkinson J; Fixon-Owoo S; Tatlisumak T; Shaw GG; Doyle KM
    Brain Res; 2006 Mar; 1076(1):209-15. PubMed ID: 16473330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effect of delayed moderate hypothermia after focal cerebral ischemia: an MRI study.
    Kollmar R; Schäbitz WR; Heiland S; Georgiadis D; Schellinger PD; Bardutzky J; Schwab S
    Stroke; 2002 Jul; 33(7):1899-904. PubMed ID: 12105372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR evaluation of calcium entry blockers with putative cerebroprotective effects in acute cerebral ischaemia.
    Kucharczyk J; Mintorovich J; Sevick R; Asgari H; Moseley M
    Acta Neurochir Suppl (Wien); 1990; 51():254-5. PubMed ID: 2089909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 2nd communication: brain penetration, cerebral vascular and metabolic effects.
    Szabo L
    Arzneimittelforschung; 1989 Mar; 39(3):309-14. PubMed ID: 2757656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging.
    Sauter A; Rudin M
    Stroke; 1986; 17(6):1228-34. PubMed ID: 2949398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
    Matsuo Y; Mihara Si ; Ninomiya M; Fujimoto M
    Stroke; 2001 Sep; 32(9):2143-8. PubMed ID: 11546909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.
    Mulcahy NJ; Ross J; Rothwell NJ; Loddick SA
    Br J Pharmacol; 2003 Oct; 140(3):471-6. PubMed ID: 12970087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death.
    Szabo L; Hofmann HP
    Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postischemic (S)-emopamil therapy ameliorates focal ischemic brain injury in rats.
    Morikawa E; Ginsberg MD; Dietrich WD; Duncan RC; Busto R
    Stroke; 1991 Mar; 22(3):355-60. PubMed ID: 2003305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nimodipine attenuates both ischaemia-induced brain oedema and mortality in a rat novel transient middle cerebral artery occlusion model.
    Hara H; Nagasawa H; Kogure K
    Acta Neurochir Suppl (Wien); 1990; 51():251-3. PubMed ID: 2089908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of atrial natriuretic peptide on ischaemic brain oedema evaluated by the proton magnetic resonance method.
    Naruse S; Aoki Y; Horikawa Y; Tanaka C; Higuchi T; Ebisu T; Ueda S; Kondo S; Kiyota T; Hayashi H
    Acta Neurochir Suppl (Wien); 1990; 51():248-50. PubMed ID: 2151010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pre-ischaemic neuroprotective effects of N1-dansyl-spermine in a transient focal cerebral ischaemia model in mice.
    Li J; Henman MC; Tatlisumak T; Shaw GG; Doyle KM
    Brain Res; 2005 Sep; 1055(1-2):180-5. PubMed ID: 16095573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogens decrease reperfusion-associated cortical ischemic damage: an MRI analysis in a transient focal ischemia model.
    Shi J; Bui JD; Yang SH; He Z; Lucas TH; Buckley DL; Blackband SJ; King MA; Day AL; Simpkins JW
    Stroke; 2001 Apr; 32(4):987-92. PubMed ID: 11283401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
    Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium entry and 5-HT2 receptor blockade in oliguric ischaemic acute renal failure: effects of levemopamil in conscious rats.
    Kramer HJ; Rosberg J; Bäcker A; Meyer-Lehnert H
    Br J Pharmacol; 1996 Mar; 117(6):1348-54. PubMed ID: 8882635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental focal cerebral ischaemia assessed with IVIM*-MRI in the acute phase at 0.5 tesla.
    Berry I; Gigaud M; Manelfe C
    Neuroradiology; 1992; 34(2):135-40. PubMed ID: 1603312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain ornithine decarboxylase activity following transient cerebral ischaemia: relationship to cerebral oedema development.
    Dempsey RJ; Combs DJ; Olson JW; Maley M
    Neurol Res; 1988 Sep; 10(3):175-8. PubMed ID: 2905781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.